Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Japon And NotEtsuro Mori

List of bibliographic references

Number of relevant bibliographic references: 205.
Ident.Authors (with country if any)Title
000033 Shinji Saiki [Japon] ; Shigeto Sato [Japon] ; Nobutaka Hattori [Japon]Molecular pathogenesis of Parkinson's disease: update
000042 Shigeki Hirano [Japon] ; Hitoshi Shinotoh [Japon] ; David Eidelberg [États-Unis]Functional brain imaging of cognitive dysfunction in Parkinson's disease
000048 Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko KrügerA multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants
000060 Husseini Manji [États-Unis] ; Tadafumi Kato [Japon] ; Nicholas A. Di Prospero [États-Unis] ; Seth Ness [États-Unis] ; M. Flint Beal [États-Unis] ; Michael Krams [États-Unis] ; Guang Chen [États-Unis]Impaired mitochondrial function in psychiatric disorders
000103 Yoichiro Kikuchi [Japon] ; Takao Yasuhara [Japon] ; Takashi Agari [Japon] ; Akihiko Kondo [Japon] ; Satoshi Kuramoto [Japon] ; Masahiro Kameda [Japon] ; Tomohito Kadota [Japon] ; Tanefumi Baba [Japon] ; Naoki Tajiri [Japon] ; Feifei Wang [Japon] ; Judith T. Tayra [Japon] ; Hanbai Liang [Japon] ; Yasuyuki Miyoshi [Japon] ; Cesario V. Borlongan [États-Unis] ; Isao Date [Japon]Urinary 8‐OHdG elevations in a partial lesion rat model of parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion
000105 S. Orimo [Japon] ; T. Uchihara [Japon] ; T. Kanazawa [Japon] ; Y. Itoh [Japon] ; K. Wakabayashi ; A. Kakita [Japon] ; H. Takahashi [Japon]Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease
000139 Kazutaka Kobayashi [États-Unis, Japon] ; Anthony E. Lang [Canada] ; Mark Hallett [États-Unis] ; Frederick A. Lenz [États-Unis]Thalamic neuronal and EMG activity in psychogenic dystonia compared with organic dystonia
000148 Namiko Nishida [Japon] ; Tokiko Murakami [Japon] ; Kunihiro Kadoh [Japon] ; Rie Tohge [Japon] ; Miki Yamanegi [Japon] ; Hidemoto Saiki [Japon] ; Keita Ueda [Japon] ; Sadayuki Matsumoto [Japon] ; Masatsune Ishikawa [Japon] ; Jun A. Takahashi [Japon] ; Hiroki Toda [Japon]Subthalamic nucleus deep brain stimulation restores normal rapid eye movement sleep in Parkinson's disease
000153 Hideyuki Matsumoto [Japon] ; Yasuo Terao [Japon] ; Toshiaki Furubayashi [Japon] ; Akihiro Yugeta [Japon] ; Hideki Fukuda [Japon] ; Masaki Emoto [Japon] ; Ritsuko Hanajima [Japon] ; Yoshikazu Ugawa [Japon]Small saccades restrict visual scanning area in Parkinson's disease
000159 Keisuke Matsubara [Japon] ; Hiroshi Watabe [Japon] ; Yoshitaka Kumakura [Japon] ; Takuya Hayashi [Japon] ; Christopher J. Endres [États-Unis] ; Kotaro Minato [Japon] ; Hidehiro Iida [Japon]Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: A simulation study for [18F]FDOPA PET by a model with detailed dopamine pathway
000183 Masayuki Watanabe [Japon, Canada] ; Douglas P. Munoz [Canada]Probing basal ganglia functions by saccade eye movements
000255 Thomas Gasser [Allemagne] ; John Hardy [Royaume-Uni] ; Yoshikuni Mizuno [Japon]Milestones in PD genetics
000319 Toshiki Uchihara [Japon]Expanding morphological dimensions in neuropathology, from sequence biology to pathological sequences and clinical consequences
000330 Y. Baba ; M. Higuchi ; K. Fukuyama ; H. Abe ; Y. Uehara [Japon] ; T. Inoue ; T. YamadaEffect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease
000334 Tomohiko Nakamura [Japon] ; Masaaki Hirayama [Japon] ; Takashi Hara [Japon] ; Tetsuo Hama [Japon] ; Hirohisa Watanabe [Japon] ; Gen Sobue [Japon]Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease?
000340 M. Iijima [Japon] ; T. Kobayakawa ; S. Saito ; M. Osawa [Japon] ; Y. Tsutsumi [Japon] ; S. Hashimoto [Japon] ; S. Uchiyama [Japon]Differences in odor identification among clinical subtypes of Parkinson’s disease
000375 H. Oka [Japon] ; C. Toyoda [Japon] ; M. Yogo [Japon] ; S. Mochio [Japon]Cardiovascular dysautonomia in de novo Parkinson’s disease without orthostatic hypotension
000378 Morinobu Seki [Japon] ; Kazushi Takahashi [Japon] ; Atsuo Koto [Japon] ; Ban Mihara [Japon] ; Yoko Morita [Japon] ; Kazuo Isozumi [Japon] ; Kouichi Ohta [Japon] ; Kazuhiro Muramatsu [Japon] ; Jun Gotoh [Japon] ; Keiji Yamaguchi [Japon] ; Yutaka Tomita [Japon] ; Hideki Sato [Japon] ; Yoshihiro Nihei [Japon] ; Satoko Iwasawa [Japon] ; Norihiro Suzuki [Japon]Camptocormia in Japanese patients with Parkinson's disease: A multicenter study
000380 Noriyuki Kimura [Japon] ; Syojirou Hanaki [Japon] ; Teruaki Masuda [Japon] ; Takuya Hanaoka [Japon] ; Yusuke Hazama [Japon] ; Toshio Okazaki [Japon] ; Ryuki Arakawa [Japon] ; Toshihide Kumamoto [Japon]Brain perfusion differences in Parkinsonian disorders
000394 Eri Himeno [Japon] ; Yasumasa Ohyagi [Japon] ; Linqing Ma [Japon] ; Norimichi Nakamura [Japon] ; Katsue Miyoshi [Japon] ; Nobutaka Sakae [Japon] ; Kyoko Motomura [Japon] ; Naoko Soejima [Japon] ; Ryo Yamasaki [Japon] ; Tetsuya Hashimoto [Japon] ; Takeshi Tabira [Japon] ; Frank M. Laferla [États-Unis] ; Jun-Ichi Kira [Japon]Apomorphine treatment in Alzheimer mice promoting amyloid‐β degradation
000396 Shinya Fujiwara [Japon] ; Fumiharu Kimura [Japon] ; Takafumi Hosokawa [Japon] ; Shimon Ishida [Japon] ; Masakazu Sugino [Japon] ; Toshiaki Hanafusa [Japon]Anhedonia in Japanese patients with Parkinson's disease
000462 Shoji Tsuji [Japon]Genetics of neurodegenerative diseases: insights from high-throughput resequencing
000494 Akira Kurita [Japon] ; Maiko Murakami [Japon] ; Satoshi Takagi [Japon] ; Masato Matsushima [Japon] ; Masahiko Suzuki [Japon]Visual hallucinations and altered visual information processing in Parkinson disease and dementia with Lewy bodies
000567 Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
000568 Manabu Funayama [Japon] ; Hiroyuki Tomiyama [Japon] ; Ruey-Meei Wu [Taïwan] ; Kotaro Ogaki [Japon] ; Hiroyo Yoshino [Japon] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon]Rapid screening of ATP13A2 variant with high‐resolution melting analysis
000569 Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000573 Hirohisa Watanabe [Japon] ; Mizuki Ito [Japon] ; Hiroshi Fukatsu [Japon] ; Jo Senda [Japon] ; Naoki Atsuta [Japon] ; Tomotsugu Kaga [Japon] ; Shigetaka Kato [Japon] ; Masahisa Katsuno [Japon] ; Fumiaki Tanaka [Japon] ; Masaaki Hirayama [Japon] ; Shinji Naganawa [Japon] ; Gen Sobue [Japon]Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy
000620 Ana I. Rojo [Espagne] ; Nadia G. Innamorato [Espagne] ; Ana M. Martín-Moreno [Espagne] ; María L. De Ceballos [Espagne] ; Masayuki Yamamoto [Japon] ; Antonio Cuadrado [Espagne]Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease
000653 Tomohiko Nakamura [Japon] ; Masaaki Hirayama [Japon] ; Fumitada Yamashita [Japon] ; Kei Uchida [Japon] ; Tetsuo Hama [Japon] ; Hirohisa Watanabe [Japon] ; Gen Sobue [Japon]Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson's disease
000685 Toshiharu Otaka [Japon] ; Hideki Oshima [Japon] ; Yoichi Katayama [Japon] ; Toshikazu Kano [Japon] ; Kazutaka Kobayashi [Japon] ; Yutaka Suzuki [Japon] ; Chikashi Fukaya [Japon] ; Takamitsu Yamamoto [Japon]Impact of Subthalamic Nucleus Stimulation on Young‐Onset Parkinson's Disease
000694 Yutaka Naito [Japon] ; Ko Matsuo [Japon] ; Yasumasa Kokubo [Japon] ; Yugo Narita [Japon] ; Hidekazu Tomimoto [Japon]Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe?
000710 Satoshi Kono [Japon] ; Yasuomi Ouchi [Japon] ; Tatsuhiro Terada [Japon] ; Hiroyuki Ida [Japon] ; Makiko Suzuki [Japon] ; Hiroaki Miyajima [Japon]Functional brain imaging in glucocerebrosidase mutation carriers with and without Parkinsonism
000731 Noriyuki Yamamoto [Japon] ; Yasuhiko Izumi [Japon] ; Takaaki Matsuo [Japon] ; Seiko Wakita [Japon] ; Toshiaki Kume [Japon] ; Yuki Takada-Takatori [Japon] ; Hideyuki Sawada [Japon] ; Akinori Akaike [Japon]Elevation of heme oxygenase‐1 by proteasome inhibition affords dopaminergic neuroprotection
000732 Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000754 Katsuji Kobayashi [Japon] ; Hisashi Sumiya [Japon] ; Hiroyuki Nakano [Japon] ; Noriko Akiyama [Japon] ; Katsumi Urata [Japon] ; Yoshifumi Koshino [Japon]Detection of Lewy body disease in patients with late‐onset depression, anxiety and psychotic disorder with myocardial meta‐iodobenzylguanidine scintigraphy
000756 Takeshi Inoue [Japon] ; Mayumi Kitagawa [Japon] ; Teruaki Tanaka [Japon] ; Shin Nakagawa [Japon] ; Tsukasa Koyama [Japon]Depression and major depressive disorder in patients with Parkinson's disease
000767 Y. Nishio [Japon] ; K. Hirayama [Japon] ; A. Takeda [Japon] ; Y. Hosokai [Japon] ; T. Ishioka [Japon] ; K. Suzuki [Japon] ; Y. Itoyama [Japon] ; S. Takahashi [Japon] ; E. Mori [Japon]Corticolimbic gray matter loss in Parkinson’s disease without dementia
000784 K. Ishibashi [Japon] ; K. Kanemaru [Japon] ; Y. Saito [Japon] ; S. Murayama [Japon] ; K. Oda [Japon] ; K. Ishiwata [Japon] ; H. Mizusawa [Japon] ; K. Ishii [Japon]Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease
000787 Mutsumi Iijima [Japon] ; Mikio Osawa [Japon] ; Mitsuru Momose [Japon] ; Tatsu Kobayakawa [Japon] ; Sachiko Saito [Japon] ; Makoto Iwata [Japon] ; Shinichiro Uchiyama [Japon]Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease
000827 K. Tanaka ; Y. Miyake ; W. Fukushima ; S. Sasaki [Japon] ; C. Kiyohara ; Y. Tsuboi ; T. Yamada ; T. Oeda ; T. Miki ; N. Kawamura ; N. Sakae ; H. Fukuyama ; Y. Hirota ; M. Nagai [Japon]Active and passive smoking and risk of Parkinson’s disease
000829 Hiroshi Nagayama [Japon] ; Masayuki Ueda [Japon] ; Mineo Yamazaki [Japon] ; Yasuhiro Nishiyama [Japon] ; Makoto Hamamoto [Japon] ; Yasuo Katayama [Japon]Abnormal cardiac [123I]‐meta‐iodobenzylguanidine uptake in multiple system atrophy
000831 M. Shioya ; S. Obayashi ; H. Tabunoki ; K. Arima ; Y. Saito ; T. Ishida [Japon] ; J. SatohAberrant microRNA expression in the brains of neurodegenerative diseases: miR‐29a decreased in Alzheimer disease brains targets neurone navigator 3
000857 Ken Ishiyama [Japon] ; Akiyoshi Takami ; Shioto Suzuki ; Hiroyuki Konaka ; Mikio Namiki ; Akifumi Ooi ; Shinji NakaoRelationship Between Tumor-infiltrating T Lymphocytes and Clinical Response After Reduced-intensity Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Renal Cell Carcinoma: A Single Center Prospective Study
000868 Yasuhiro Nagahama [Japon] ; Tomoko Okina [Japon] ; Norio Suzuki [Japon] ; Minoru Matsuda [Japon]Neural correlates of psychotic symptoms in dementia with Lewy bodies
000904 Toyoki Maeda [Japon] ; Jing Zhi Guan [Japon] ; Jun-Ichi Oyama [Japon] ; Yoshihiro Higuchi [Japon] ; Naoki Makino [Japon]Aging-Associated Alteration of Subtelomeric Methylation in Parkinson's Disease
000927 Cristine Alves Da Costa [France] ; Claire Sunyach [France] ; Emilie Giaime [France] ; Andrew West [États-Unis] ; Olga Corti [France] ; Alexis Brice [France] ; Stephen Safe [États-Unis] ; Patrick M. Abou-Sleiman [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Hitoshi Takahashi [Japon] ; Mathew S. Goldberg [États-Unis] ; Jie Shen [États-Unis] ; Frdric Checler [France]Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease
000A13 Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Masaoki Iwanami [Japon] ; Keisuke Suzuki [Japon] ; Yuichi Inoue [Japon] ; Koichi Hirata [Japon]Odor identification test as an indicator of idiopathic REM sleep behavior disorder
000A14 Hiroki Takeuchi [Japon] ; Takashi Yanagida [Japon] ; Masatoshi Inden [Japon] ; Kazuyuki Takata [Japon] ; Yoshihisa Kitamura [Japon] ; Kentaro Yamakawa [Japon] ; Hideyuki Sawada [Japon] ; Yasuhiko Izumi [Japon] ; Noriyuki Yamamoto [Japon] ; Takeshi Kihara [Japon] ; Kengo Uemura [Japon] ; Haruhisa Inoue [Japon] ; Takashi Taniguchi [Japon] ; Akinori Akaike [Japon] ; Ryosuke Takahashi [Japon] ; Shun Shimohama [Japon]Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone‐induced Parkinson's disease models
000A22 Shin-Ichi Muramatsu [Japon] ; Tsuyoshi Okuno [Japon] ; Yutaka Suzuki [Japon] ; Takashi Nakayama [Japon] ; Takeharu Kakiuchi [Japon] ; Naomi Takino [Japon] ; Asako Iida [Japon] ; Fumiko Ono [Japon] ; Keiji Terao [Japon] ; Nobuo Inoue [Japon] ; Imaharu Nakano [Japon] ; Yasushi Kondo [Japon] ; Hideo Tsukada [Japon]Multitracer assessment of dopamine function after transplantation of embryonic stem cell‐derived neural stem cells in a primate model of Parkinson's disease
000A36 Shigeki Hirano [États-Unis, Japon] ; Thomas Eckert [États-Unis, Allemagne] ; Toni Flanagan [États-Unis] ; David Eidelberg [États-Unis]Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease
000A53 Cyrus P. Zabetian [États-Unis] ; Mitsutoshi Yamamoto [Japon] ; Alexis N. Lopez [États-Unis] ; Hiroshi Ujike [Japon] ; Ignacio F. Mata [États-Unis] ; Yuishin Izumi [Japon] ; Ryuji Kaji [Japon] ; Hirofumi Maruyama [Japon] ; Hiroyuki Morino [Japon] ; Masaya Oda [Japon] ; Carolyn M. Hutter [États-Unis] ; Karen L. Edwards [États-Unis] ; Gerard D. Schellenberg [États-Unis] ; Debby W. Tsuang [États-Unis] ; Dora Yearout [États-Unis] ; Eric B. Larson [États-Unis] ; Hideshi Kawakami [Japon]LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease
000A78 Yumi Sakakibara [Japon] ; Masato Asahina [Japon] ; Atsuya Suzuki [Japon] ; Takamichi Hattori [Japon]Gastric myoelectrical differences between Parkinson's disease and multiple system atrophy
000A83 Osamu Yokota [Japon]Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis
000A85 Yasuyuki Okuma [Japon] ; Satoshi Kamei [Japon] ; Akihiko Morita [Japon] ; Fumihito Yoshii [Japon] ; Toshimasa Yamamoto [Japon] ; Shiori Hashimoto [Japon] ; Hiroya Utsumi [Japon] ; Taku Hatano [Japon] ; Nobutaka Hattori [Japon] ; Miyuki Matsumura [Japon] ; Kazushi Takahashi [Japon] ; Shigeru Nogawa [Japon] ; Yuka Watanabe [Japon] ; Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Koichi Hirata [Japon]Fatigue in Japanese patients with Parkinson's disease: A study using Parkinson fatigue scale
000A91 Kenya Nishioka [Japon, États-Unis] ; Owen A. Ross [États-Unis] ; Kenji Ishii [Japon] ; Jennifer M. Kachergus [États-Unis] ; Kiichi Ishiwata [Japon] ; Mayumi Kitagawa [Japon] ; Satoshi Kono [Japon] ; Tomokazu Obi [Japon] ; Koichi Mizoguchi [Japon] ; Yuichi Inoue [Japon] ; Hisamasa Imai [Japon] ; Masashi Takanashi [Japon] ; Yoshikuni Mizuno [Japon] ; Matthew J. Farrer [États-Unis] ; Nobutaka Hattori [Japon]Expanding the clinical phenotype of SNCA duplication carriers
000B17 H. Sawada [Japon] ; T. Oeda [Japon] ; K. Yamamoto [Japon] ; N. Kitagawa [Japon] ; E. Mizuta [Japon] ; R. Hosokawa [Japon] ; M. Ohba [Japon] ; R. Nishio [Japon] ; K. Yamakawa [Japon] ; H. Takeuchi [Japon] ; S. Shimohama [Japon] ; R. Takahashi [Japon] ; T. Kawamura [Japon]Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease
000B24 Yasushi Osaki [Japon] ; Yukari Morita [Japon] ; Mitsutaka Fukumoto [Japon] ; Naoki Akagi [Japon] ; Shoji Yoshida [Japon] ; Yoshinori Doi [Japon]Cross‐sectional and longitudinal studies of three‐dimensional stereotactic surface projection SPECT analysis in Parkinson's disease
000B39 Takashi Haraguchi ; Seishi Terada ; Hideki Ishizu ; Kenichi Sakai ; Yasuyuki Tanabe ; Taiji Nagai ; Hiroshi Takata ; Keigo Nobukuni ; Yuetsu Ihara ; Tetsuyuki Kitamoto [Japon] ; Shigetoshi KurodaCoexistence of Creutzfeldt‐Jakob disease, Lewy body disease, and Alzheimer's disease pathology: An autopsy case showing typical clinical features of Creutzfeldt‐Jakob disease
000B53 Helen Petrovitch [États-Unis] ; Robert D. Abbott [États-Unis, Japon] ; G. Webster Ross [États-Unis] ; James Nelson [États-Unis] ; Kamal H. Masaki [États-Unis] ; Caroline M. Tanner [États-Unis] ; Lenore J. Launer [États-Unis] ; Lon R. White [États-Unis]Bowel movement frequency in late‐life and substantia nigra neuron density at death
000C15 Tomoki Kuwahara ; Akihiko Koyama ; Shingo Koyama ; Sawako Yoshina ; Chang-Hong Ren ; Takeo Kato ; Shohei Mitani ; Takeshi Iwatsubo [Japon]A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in -synuclein transgenic C. elegans
000C49 Yasuyuki Okuma [Japon] ; Nobuo Yanagisawa [Japon]The clinical spectrum of freezing of gait in Parkinson's disease
000C63 Robert A. Hauser [États-Unis] ; Lisa M. Shulman [États-Unis] ; Joel M. Trugman [États-Unis] ; John W. Roberts [États-Unis] ; Akihisa Mori [Japon] ; Rocco Ballerini [États-Unis] ; Neil M. Sussman [États-Unis]Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
000D35 Jun-Ichi Satoh ; Shinya Obayashi ; Tamako Misawa ; Hiroko Tabunoki ; Takashi Yamamura ; Kunimasa Arima ; Hidehiko Konno [Japon]Neuromyelitis optica/Devic's disease: Gene expression profiling of brain lesions
000D58 Xuemei Huang [États-Unis] ; Robert D. Abbott [États-Unis, Japon] ; Helen Petrovitch [États-Unis] ; Richard B. Mailman [États-Unis] ; G. Webster Ross [États-Unis]Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu‐Asia Aging Study
000D80 Masashi Hamada [Japon] ; Yoshikazu Ugawa [Japon] ; Sadatoshi Tsuji [Japon]High‐frequency rTMS over the supplementary motor area for treatment of Parkinson's disease
000D89 Owen A. Ross [États-Unis] ; Adam T. Braithwaite [États-Unis] ; Lisa M. Skipper [États-Unis] ; Jennifer Kachergus [États-Unis] ; Mary M. Hulihan [États-Unis] ; Frank A. Middleton [États-Unis] ; Kenya Nishioka [Japon] ; Julia Fuchs [Allemagne] ; Thomas Gasser [Allemagne] ; Demetrius M. Maraganore [États-Unis] ; Charles H. Adler [États-Unis] ; Lydie Larvor [France] ; Marie-Christine Chartier-Harlin [France] ; Christer Nilsson [Suède] ; J. William Langston [États-Unis] ; Katrina Gwinn [États-Unis] ; Nobutaka Hattori [Japon] ; Matthew J. Farrer [États-Unis]Genomic investigation of α‐synuclein multiplication and parkinsonism
000E04 K. Imamura [Japon] ; K. Wada-Isoe [Japon] ; M. Kitayama [Japon] ; K. Nakashima [Japon]Executive dysfunction in non‐demented Parkinson’s disease patients with hallucinations
000E15 Masaki Wakamatsu [Japon] ; Shingo Iwata [Japon] ; Takeo Funakoshi [Japon] ; Makoto Yoshimoto [Japon]Dopamine receptor agonists reverse behavioral abnormalities of α‐synuclein transgenic mouse, a new model of Parkinson's disease
000E62 G. Webster Ross [États-Unis] ; Helen Petrovitch [États-Unis] ; Robert D. Abbott [États-Unis, Japon] ; Caroline M. Tanner [États-Unis] ; Jordan Popper [États-Unis] ; Kamal Masaki [États-Unis] ; Lenore Launer [États-Unis] ; Lon R. White [États-Unis]Association of olfactory dysfunction with risk for future Parkinson's disease
000E63 K. Wada-Isoe [Japon] ; K. Ohta [Japon] ; K. Imamura [Japon] ; M. Kitayama [Japon] ; T. Nomura [Japon] ; K. Yasui [Japon] ; K. Nakaso [Japon] ; K. Nakashima [Japon]Assessment of hallucinations in Parkinson’s disease using a novel scale
000E73 Peter A. Lewitt [États-Unis] ; M. Guttman [Canada] ; James W. Tetrud [États-Unis] ; Paul J. Tuite [États-Unis] ; Akihisa Mori [Japon] ; Philip Chaikin [États-Unis] ; Neil M. Sussman [États-Unis]Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)
000E90 Hisayoshi Oka [Japon] ; Masayuki Yoshioka [Japon] ; Kenji Onouchi [Japon] ; Masayo Morita [Japon] ; Soichiro Mochio [Japon] ; Masahiko Suzuki [Japon] ; Toshiaki Hirai [Japon] ; Yasuhiko Ito [Japon] ; Kiyoharu Inoue [Japon]Retracted: Characteristics of orthostatic hypotension in Parkinson's disease
000F09 Satoshi Orimo [Japon] ; Toshiki Uchihara [Japon] ; Ayako Nakamura [Japon] ; Fumiaki Mori [Japon] ; Akiyoshi Kakita [Japon] ; Koichi Wakabayashi [Japon] ; Hitoshi Takahashi [Japon]Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease
000F26 Risa Sakai [Japon] ; Yoshifumi Irie [Japon] ; Takeshi Murata [Japon] ; Atsushi Ishige [Japon] ; Naoko Anjiki [Japon] ; Kenji Watanabe [Japon]Toki‐to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice
000F37 Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Richard G. Brown [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] ; Per Odin [Allemagne] ; William Ondo [États-Unis] ; Kazuo Abe [Japon] ; Graeme Macphee [Royaume-Uni] ; Doug Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Warren Olanow [États-Unis] ; Adrian J. Williams [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Yoshio Tsuboi [Japon] ; Annette Hand [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni]The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study
000F40 Koichi Wakabayashi ; Kunikazu Tanji ; Fumiaki Mori ; Hitoshi Takahashi [Japon]The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
000F46 Takeshi Iwatsubo [Japon]THIS ARTICLE HAS BEEN RETRACTED: Pathological biochemistry of α‐synucleinopathy
000F59 Lianna Ishihara [Royaume-Uni] ; Rachel A. Gibson [Royaume-Uni] ; Liling Warren [États-Unis] ; Rim Amouri [Tunisie] ; Kelly Lyons [États-Unis] ; Catherine Wielinski [États-Unis] ; Christine Hunter [États-Unis] ; Jina E. Swartz [Royaume-Uni] ; Ramu Elango [Royaume-Uni] ; P. Anthony Akkari [États-Unis] ; David Leppert [Royaume-Uni] ; Linda Surh [Royaume-Uni] ; Kevin H. Reeves [États-Unis] ; Siwan Thomas [Royaume-Uni] ; Leigh Ragone [États-Unis] ; Nobutaka Hattori [Japon] ; Rajesh Pahwa [États-Unis] ; Joseph Jankovic [États-Unis] ; Martha Nance [États-Unis] ; Alan Freeman [États-Unis] ; Neziha Gouider-Khouja [Tunisie] ; Mounir Kefi [Tunisie] ; Mourad Zouari [Tunisie] ; Samia Ben Sassi [Tunisie] ; Samia Ben Yahmed [Tunisie] ; Ghada El Euch-Fayeche [Tunisie] ; Lefkos Middleton [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Ray L. Watts [États-Unis] ; Faycal Hentati [Tunisie]Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families
000F78 Yuji Nagai [Japon] ; Shigeru Obayashi [Japon] ; Kiyoshi Ando [Japon] ; Motoki Inaji [Japon] ; Jun Maeda [Japon] ; Takashi Okauchi [Japon] ; Hiroshi Ito [Japon] ; Tetsuya Suhara [Japon]Progressive changes of pre‐ and post‐synaptic dopaminergic biomarkers in conscious MPTP‐treated cynomolgus monkeys measured by positronemission tomography
000F82 H. Ishii [Japon] ; K. Meguro [Japon] ; S. Yamaguchi [Japon] ; H. Ishikawa [Japon] ; A. Yamadori [Japon]Prevalence and cognitive performances of vascular cognitive impairment no dementia in Japan: the Osaki–Tajiri Project
001026 Osamu Yokota ; Kuniaki Tsuchiya ; Toshiki Uchihara ; Hiroshi Ujike ; Seishi Terada ; Mafuyu Takahashi ; Yuji Kimura ; Hideki Ishizu [Japon] ; Haruhiko Akiyama ; Shigetoshi KurodaLewy body variant of Alzheimer’s disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem
001027 Giovanni Fabbrini [Italie] ; Jonathan M. Brotchie [Canada] ; Francisco Grandas [Espagne] ; Masahiro Nomoto [Japon] ; Christopher G. Goetz [États-Unis]Levodopa‐induced dyskinesias
001038 Hisayoshi Oka [Japon] ; Masayuki Yoshioka [Japon] ; Kenji Onouchi [Japon] ; Masayo Morita [Japon] ; Soichiro Mochio [Japon] ; Masahiko Suzuki [Japon] ; Toshiaki Hirai [Japon] ; Mitsuyoshi Urashima [Japon] ; Kiyoharu Inoue [Japon]Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinations
001056 Shoichi Ito [Japon] ; Wakako Shirai [Japon] ; Takamichi Hattori [Japon]Evaluating posterolateral linearization of the putaminal margin with magnetic resonance imaging to diagnose the Parkinson variant of multiple system atrophy
001075 Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
001082 H. Matsui [Japon] ; K. Nishinaka [Japon] ; M. Oda [Japon] ; H. Niikawa [Japon] ; T. Kubori [Japon] ; F. Udaka [Japon]Dementia in Parkinson’s disease: diffusion tensor imaging
001084 Satoshi Orimo [Japon] ; Atsushi Takahashi [Japon] ; Toshiki Uchihara [Japon] ; Fumiaki Mori [Japon] ; Akiyoshi Kakita [Japon] ; Koichi Wakabayashi [Japon] ; Hitoshi Takahashi [Japon]Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s Disease
001097 M. Kitayama [Japon] ; K. Wada-Isoe [Japon] ; K. Nakaso [Japon] ; Y. Irizawa [Japon] ; K. Nakashima [Japon]Clinical evaluation of Parkinson’s disease dementia: association with aging and visual hallucination
001098 Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France]Clinical diagnostic criteria for dementia associated with Parkinson's disease
001104 Hiroyuki Kinoshita ; Hirohiko Hirano ; Akihiko Hosoya ; Tadashi Ninomiya ; Hidehiro Ozawa ; Motoji Sawabe ; Yasuyoshi Ouchi ; Masatsune Yamaguchi ; Takayuki Hosoi [Japon]Case of bone Paget's disease with cheek pain, hearing loss and tremor whose histological findings showed peculiar calcified structures
001106 Robert D. Abbott [États-Unis, Japon] ; G. Webster Ross [États-Unis] ; Helen Petrovitch [États-Unis] ; Caroline M. Tanner [États-Unis] ; Daron G. Davis [États-Unis] ; Kamal H. Masaki [États-Unis] ; Lenore J. Launer [États-Unis] ; J. David Curb [États-Unis] ; Lon R. White [États-Unis]Bowel movement frequency in late‐life and incidental Lewy bodies
001115 Kenjiro Ono [Japon] ; Mie Hirohata [Japon] ; Masahito Yamada [Japon]Anti‐fibrillogenic and fibril‐destabilizing activities of anti‐Parkinsonian agents for α‐synuclein fibrils in vitro
001121 Masayuki Shintaku ; Kiyomitsu Oyanagi [Japon] ; Daita KanedaAmyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: Report of an autopsy case
001128 Masaki Wakamatsu [Japon] ; Aiko Ishii [Japon] ; Yuriko Ukai [Japon] ; Junko Sakagami [Japon] ; Shingo Iwata [Japon] ; Mieko Ono [Japon] ; Kayo Matsumoto [Japon] ; Atsushi Nakamura [Japon] ; Norihiro Tada [Japon] ; Kazuto Kobayashi [Japon] ; Takeshi Iwatsubo [Japon] ; Makoto Yoshimoto [Japon]Accumulation of phosphorylated α‐synuclein in dopaminergic neurons of transgenic mice that express human α‐synuclein
001131 Yoshitaka Nagai [Japon] ; Takashi Inui [Japon] ; H Akiko Popiel [Japon] ; Nobuhiro Fujikake [Japon] ; Kazuhiro Hasegawa [Japon] ; Yoshihiro Urade [Japon] ; Yuji Goto [Japon] ; Hironobu Naiki [Japon] ; Tatsushi Toda [Japon]A toxic monomeric conformer of the polyglutamine protein
001150 Kenichi Nishida ; Shinzi Itoh ; Naohide Inoue [Japon] ; Keiko Kudo ; Noriaki Ikeda [Japon]High-Performance Liquid Chromatographic-Mass Spectrometric Determination of Methamphetamine and Amphetamine Enantiomers, Desmethylselegiline and Selegiline, in Hair Samples of Long-Term Methamphetamine Abusers or Selegiline Users
001210 Shin-Ichiro Kubo [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon]Recessive Parkinson's disease
001217 Kazumichi Yamada [Japon] ; Satoshi Goto [Japon] ; Kazuhito Matsuzaki ; Shinji Nagahiro ; Nagako Murase [Japon] ; Hideki Shimazu [Japon] ; Ryuji Kaji [Japon] ; Jun-Ichi Kuratsu [Japon] ; Yukitaka Ushio [Japon]Psychiatric Symptoms and Subthalamic Nucleus Stimulation in Parkinson's Disease. A Retrospective Study in Our Japanese Patients
001222 Kenichi Sato [Japon] ; Taku Hatano [Japon] ; Kazuo Yamashiro [Japon] ; Maki Kagohashi [Japon] ; Kenya Nishioka [Japon] ; Nana Izawa [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Hideo Mori [Japon] ; Yoshikuni Mizuno [Japon]Prognosis of Parkinson's disease: Time to stage III, IV, V, and to motor fluctuations
001258 Ikuko Mizuta ; Wataru Satake ; Yuko Nakabayashi ; Chiyomi Ito ; Satoko Suzuki ; Yoshio Momose ; Yoshitaka Nagai ; Akira Oka ; Hidetoshi Inoko ; Jiro Fukae ; Yuko Saito ; Motoji Sawabe ; Shigeo Murayama ; Mitsutoshi Yamamoto ; Nobutaka Hattori ; Miho Murata [Japon] ; Tatsushi Toda [Japon]Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease
001268 Saskia Biskup [États-Unis] ; Darren J. Moore [États-Unis] ; Fulvio Celsi [Norvège] ; Shinji Higashi [Japon, Royaume-Uni] ; Andrew B. West [États-Unis] ; Shaida A. Andrabi [États-Unis] ; Kaisa Kurkinen [États-Unis] ; Seong-Woon Yu [États-Unis] ; Joseph M. Savitt [États-Unis] ; Henry J. Waldvogel [Nouvelle-Zélande] ; Richard L. M. Faull [Nouvelle-Zélande] ; Piers C. Emson [Royaume-Uni] ; Reidun Torp [Norvège] ; Ole P. Ottersen [Norvège] ; Ted M. Dawson [États-Unis] ; Valina L. Dawson [États-Unis]Localization of LRRK2 to membranous and vesicular structures in mammalian brain
001284 Hideaki Kobayashi [Japon] ; Hiroshi Ujike [Japon] ; Junko Hasegawa [Japon] ; Mitsutoshi Yamamoto [Japon] ; Akihiro Kanzaki [Japon] ; Ichiro Sora [Japon]Identification of a risk haplotype of the α‐synuclein gene in Japanese with sporadic Parkinson's disease
001338 Kenya Nishioka [Japon] ; Shin Hayashi [Japon] ; Matthew J. Farrer [États-Unis] ; Andrew B. Singleton [États-Unis] ; Hiroyo Yoshino ; Hisamasa Imai [Japon] ; Toshiaki Kitami [Japon] ; Kenichi Sato [Japon] ; Ryu Kuroda ; Hiroyuki Tomiyama [Japon] ; Koichi Mizoguchi ; Miho Murata [Japon] ; Tatsushi Toda [Japon] ; Issei Imoto [Japon] ; Johji Inazawa [Japon] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon]Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease
001345 H. Oka [Japon] ; S. Mochio [Japon] ; M. Yoshioka [Japon] ; M. Morita [Japon] ; K. Onouchi [Japon] ; K. Inoue [Japon]Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy[This article has been retracted]
001436 Moussa B. H. Youdim [Israël] ; Orit Bar Am [Israël] ; Merav Yogev-Falach [Israël] ; Orly Weinreb [Israël] ; Wakako Maruyama [Japon] ; Makato Naoi [Japon] ; Tamar Amit [Israël]Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition
001437 Katsumi Tsuchiya [Japon] ; Hisao Tajima [Japon] ; Toyoyasu Kuwae [Japon] ; Takao Takeshima [Japon] ; Toshiya Nakano [Japon] ; Masaharu Tanaka [Japon] ; Katsuyoshi Sunaga [Japon] ; Yoko Fukuhara [Japon] ; Kenji Nakashima [Japon] ; Eisaku Ohama [Japon] ; Hideki Mochizuki [Japon] ; Yoshikuni Mizuno [Japon] ; Nobuo Katsube [Japon] ; Ryoichi Ishitani [Japon]Pro‐apoptotic protein glyceraldehyde‐3‐phosphate dehydrogenase promotes the formation of Lewy body‐like inclusions
001439 Takeshi Amino [Japon] ; Satoshi Orimo [Japon] ; Yoshinori Itoh [Japon] ; Atsushi Takahashi [Japon] ; Toshiki Uchihara [Japon] ; Hidehiro Mizusawa [Japon]Profound Cardiac Sympathetic Denervation Occurs in Parkinson Disease
001454 Ryoko Yamamoto ; Eizo Iseki ; Wami Marui ; Takashi Togo ; Omi Katsuse ; Masanori Kato ; Daisuke Isojima [Japon] ; Hiroyasu Akatsu [Japon] ; Kenji Kosaka [Japon] ; Heii AraiNon‐uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies
001467 Yasuomi Ouchi ; Etsuji Yoshikawa [Japon] ; Yoshimoto Sekine [Japon] ; Masami Futatsubashi [Japon] ; Toshihiko Kanno ; Tomomi Ogusu [Japon] ; Tatsuo TorizukaMicroglial activation and dopamine terminal loss in early Parkinson's disease
001479 Masayuki Sugie [Japon] ; Jun Goto [Japon] ; Mitsuru Kawamura ; Hidekazu Ota [Japon]Increased norepinephrine‐associated adrenomedullary inclusions in Parkinson's disease
001492 M. Mishina [Japon] ; K. Ishiwata [Japon] ; K. Ishii [Japon] ; S. Kitamura [Japon] ; Y. Kimura [Japon] ; K. Kawamura [Japon] ; K. Oda [Japon] ; T. Sasaki [Japon] ; O. Sakayori [Japon] ; M. Hamamoto [Japon] ; S. Kobayashi [Japon] ; Y. Katayama [Japon]Function of sigma1 receptors in Parkinson's disease
001532 Darren J. Moore ; Li Zhang ; Juan Troncoso ; Michael K. Lee ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon] ; Ted M. Dawson ; Valina L. Dawson [États-Unis]Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress
001542 Carolyn F. Orr ; Dominic B. Rowe ; Yoshikuni Mizuno [Japon] ; Hideo Mori [Japon] ; Glenda M. HallidayA possible role for humoral immunity in the pathogenesis of Parkinson's disease
001554 Masaki Sekine [Japon, États-Unis] ; Metin Akay [États-Unis] ; Toshiyo Tamura [Japon] ; Yuji Higashi [Japon] ; Toshiro Fujimoto [Japon]Fractal dynamics of body motion in patients with Parkinson's disease
001559 Yoshiko Furukawa ; Eizo Iseki ; Hiroaki Hino ; Akiko Kanai ; Toshinari Odawara ; Kenji Kosaka [Japon]Ubiquitin and ubiquitin‐related proteins in neurons and dendrites of brains of atypical Pick's disease without Pick bodies
001611 Yume Okada [Japon] ; Yuji Ito ; Junko Aida ; Masahiro Yasuhara ; Shin-Ichiro Ohkawa ; Katsuiku Hirokawa [Japon]Lewy bodies in the sinoatrial nodal ganglion: Clinicopathological studies
001613 C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]Levodopa in the treatment of Parkinson's disease: Current controversies
001638 H. Furumoto [Japon]Excessive daytime somnolence in Japanese patients with Parkinson's disease
001738 Junko Takahashi-Fujigasaki [Japon]Neuronal intranuclear hyaline inclusion disease
001761 Hideo Mori [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon]Genotype–phenotype correlation: Familial Parkinson disease
001806 Masayo Shamoto-Nagai [Japon] ; Wakako Maruyama [Japon] ; Yoji Kato [Japon] ; Ken-Ichi Isobe [Japon] ; Masashi Tanaka [Japon] ; Makoto Naoi [Japon] ; Toshihiko Osawa [Japon]An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH‐SY5Y cells
001811 Shingo Okabe [Japon] ; Yoshikazu Ugawa [Japon] ; Ichiro Kanazawa [Japon]0.2‐Hz repetitive transcranial magnetic stimulation has no add‐on effects as compared to a realistic sham stimulation in Parkinson's disease
001859 Kuniaki Tsuchiya ; Kenji Ikeda ; Kazuhiro Niizato ; Sadakiyo Watabiki ; Midori Anno ; Kazuhiro Taki [Japon] ; Chie Haga ; Shuji Iritani ; Masaaki MatsushitaParkinson’s disease mimicking senile dementia of the Alzheimer type: a clinicopathological study of four autopsy cases
001863 Tatsuro Hiraki [Japon] ; Hisao Ikeda [Japon] ; Teruhisa Yoshida [Japon] ; Tomohito Inage [Japon] ; Masatsugu Ohe [Japon] ; Hitoshi Ohtsubo [Japon] ; Manabu Matsumoto [Japon] ; Takashi Hamada [Japon] ; Ichiro Kubara [Japon] ; Tsutomu Imaizumi [Japon]P Wave Signal‐Averaged Electrocardiography Predicts Recurrence of Paroxysmal Atrial Fibrillation in Patients with Wolff‐Parkinson‐White Syndrome Who Underwent Successful Catheter Ablation: A Prospective Study
001877 Takashi Hamada [Japon] ; Tatsuro Hiraki [Japon] ; Hisao Ikeda [Japon] ; Ichiro Kubara [Japon] ; Teruhisa Yoshida [Japon] ; Masanobu Ohga [Japon] ; Tsutomu Imaizumi [Japon]Mechanisms for Atrial Fibrillation in Patients with Wolff‐Parkinson‐White Syndrome
001893 Kojiro Nakao [Japon] ; Shinji Seto [Japon] ; Chiaki Ueyama [Japon] ; Kiyotaka Matsuo [Japon] ; Norihiro Komiya [Japon] ; Shojiro Isomoto [Japon] ; Katsusuke Yano [Japon]Extended Distribution of Prolonged and Fractionated Right Atrial Electrograms Predicts Development of Chronic Atrial Fibrillation in Patients with Idiopathic Paroxysmal Atrial Fibrillation
001919 Yong B. Lee [Canada, Corée du Sud] ; Atsushi Nagai [Canada, Japon] ; Seung U. Kim [Canada, Corée du Sud]Cytokines, chemokines, and cytokine receptors in human microglia
001930 Yasunobu Takada [Japon] ; Yasuya Inden [Japon] ; Makoto Akahoshi [Japon] ; Yoshihisa Shibata [Japon] ; Atsuya Shimizu [Japon] ; Yukihiko Yoshida [Japon] ; Takumi Yamada [Japon] ; Naoya Tsuboi [Japon] ; Haruo Hirayama [Japon] ; Teruo Ito [Japon] ; Takahisa Kondo [Japon] ; Hidehiko Saito [Japon] ; Makoto Hirai [Japon]Changes in Repolarization Properties with Long‐Term Cardiac Memory Modify Dispersion of Repolarization in Patients with Wolff‐Parkinson‐White Syndrome
001945 Yasuhiro Kawamoto [Japon] ; Ichiro Akiguchi [Japon] ; Shinichi Nakamura [Japon] ; Herbert Budka [Autriche]Accumulation of 14‐3‐3 proteins in glial cytoplasmic inclusions in multiple system atrophy
001956 Ryuji Sakakibara [Japon] ; Hitoshi Shinotoh [Japon] ; Tomoyuki Uchiyama [Japon] ; Mitsuharu Yoshiyama [Japon] ; Takamichi Hattori [Japon] ; Tomonori Yamanishi [Japon]SPECT imaging of the dopamine transporter with [123I]-β-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction
001976 Seiichiro Shimazu [Japon] ; Kazue Takahata [Japon] ; Hiroshi Katsuki [Japon] ; Hiroko Tsunekawa [Japon] ; Akie Tanigawa [Japon] ; Fumio Yoneda [Japon] ; Joseph Knoll [Hongrie] ; Akinori Akaike [Japon](−)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release
001989 Yasushi Arai [Japon] ; Mineo Yamazaki [Japon] ; Osamu Mori [Japon] ; Hiromi Muramatsu [Japon] ; Goro Asano [Japon] ; Yasuo Katayama [Japon]α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation
001996 Masahiko Suzuki [États-Unis, Japon] ; Timothy J. Desmond [États-Unis] ; Roger L. Albin [États-Unis] ; Kirk A. Frey [États-Unis]Vesicular neurotransmitter transporters in Huntington's disease: Initial observations and comparison with traditional synaptic markers
001A08 Hitoshi Takahashi ; Koichi Wakabayashi [Japon]The cellular pathology of Parkinson's disease
001A30 Yasuya Inden [Japon] ; Makoto Hirai [Japon] ; Yasunobu Takada [Japon] ; Atsuya Shimizu [Japon] ; Keiko Shimokata [Japon] ; Yukihiko Yoshida [Japon] ; Makoto Akahoshi [Japon] ; Takahisa Kondo [Japon] ; Hidehiko Saito [Japon]Prolongation of Activation‐Recovery Interval over a Preexcited Region before and after Catheter Ablation in Patients with Wolff‐Parkinson‐White Syndrome
001A41 Takahiro Fukuda [Japon]Neurotoxicity of MPTP
001A81 Nobuyuki Takechi [Japon] ; Takashi Seki [Japon] ; Takashi Ohkubo [Japon] ; Shunichi Ogawa [Japon]Dobutamine stress surface mapping of myocardial ischemia in Kawasaki disease
001A88 Yuko Aomi [Japon] ; Chu-Shih Chen [Japon] ; Kazuto Nakada [Japon] ; Sayaka Ito [Japon] ; Kotoyo Isobe [Japon] ; Haruka Murakami [Japon] ; Shin-Ya Kuno [Japon] ; Masato Tawata [Japon] ; Rumiko Matsuoka [Japon] ; Hidehiro Mizusawa [Japon] ; Jun-Ichi Hayashi [Japon]Cytoplasmic Transfer of Platelet mtDNA from Elderly Patients with Parkinson's Disease to mtDNA-less HeLa Cells Restores Complete Mitochondrial Respiratory Function
001B02 K. Shimizu [Japon] ; K. Ohtaki [Japon] ; K. Matsubara [Japon] ; K. Aoyama [Japon] ; T. Uezono [Japon] ; O. Saito [Japon] ; M. Suno [Japon] ; K. Ogawa [Japon] ; N. Hayase [Japon] ; K. Kimura [Japon] ; H. Shiono [Japon]Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat
001B17 Isao Araki [Japon] ; Mitsuteru Kitahara [Japon] ; Tomoyuki Oida [Japon] ; Sadako Kuno [Japon]VOIDING DYSFUNCTION AND PARKINSON'S DISEASE: URODYNAMIC ABNORMALITIES AND URINARY SYMPTOMS
001B40 Xin Su [Japon] ; Morie Sekiguchi [Japon] ; Masahiro Endo [Japon]An Ultrastructural Study of Cardiac Myocytes in Postmyocardial Infarction Ventricular Aneurysm Representative of Chronic Ischemic Myocardium Using Semiquantitative and Quantitative Assessment
001B50 K. Ancolio [France] ; C. Alves Da Costa [France] ; K. Uéda [Japon] ; F. Checler [France]α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
001B56 Ichiro Miyai [Japon] ; Yasuyuki Fujimoto [Japon] ; Yoshishige Ueda [Japon] ; Hiroshi Yamamoto [Japon] ; Sonoko Nozaki [Japon] ; Toshio Saito [Japon] ; Jin Kang [Japon]Treadmill training with body weight support: Its effect on Parkinson's disease
001B79 Kazuo Abe [Japon] ; Haruhiko Terakawa [Japon] ; Mayako Takanashi [Japon] ; Yoshiyuki Watanabe [Japon] ; Hisashi Tanaka [Japon] ; Norihiko Fujita [Japon] ; Norio Hirabuki [Japon] ; Takehiko Yanagihara [Japon]Proton magnetic resonance spectroscopy of patients with parkinsonism
001C11 K. Inoue ; H. Igarashi ; J. Fukushige ; T. Ohno ; K. Joh-O [Japon] ; T. HaraLong‐term prospective study on the natural history of Wolff‐Parkinson‐White syndrome detected during a heart screening program at school
001C31 Atsuko S. Nagano [Japon] ; Kengo Ito [Japon] ; Takashi Kato [Japon] ; Yutaka Arahata [Japon] ; Teruhiko Kachi [Japon] ; Kentaro Hatano [Japon] ; Yasuhiro Kawasumi [Japon] ; Akinori Nakamura [Japon] ; Takako Yamada [Japon] ; Yuji Abe [Japon] ; Takeo Ishigaki [Japon]Extrastriatal Mean Regional Uptake of Fluorine-18-FDOPA in the Normal Aged Brain—An Approach Using MRI-Aided Spatial Normalization
001C69 L. Wang [Japon] ; Y. Kuroiwa [Japon] ; T. Kamitani [Japon]Visual event-related potential changes at two different tasks in nondemented Parkinson’s disease
001D05 S. Ueda [Japon] ; M. Aikawa [Japon] ; A. Ishizuya-Oka [Japon] ; S. Yamaoka [Japon] ; N. Koibuchi [Japon] ; K. Yoshimoto [Japon]Age-related dopamine deficiency in the mesostriatal dopamine system of zitter mutant rats: regional fiber vulnerability in the striatum and the olfactory tubercle
001D50 Yasuomi Ouchi [Japon] ; Toshihiko Kanno [Japon] ; Hiroyuki Okada [Japon] ; Etsuji Yoshikawa [Japon] ; Masami Futatsubashi [Japon] ; Shuji Nobezawa [Japon] ; Tatsuo Torizuka [Japon] ; Masanobu Sakamoto [Japon]Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: A double‐tracer positron emission tomography study
001D84 Y. Mizuno [Japon] ; N. Hattori [Japon] ; H. Mori [Japon]Genetics of Parkinson's disease
001D94 Lihong Wang [Japon] ; Yoshiyuki Kuroiwa [Japon] ; Toshiaki Kamitani [Japon] ; Tatsuya Takahashi [Japon] ; Yume Suzuki [Japon] ; Osamu Hasegawa [Japon]Effect of interstimulus interval on visual P300 in Parkinson’s disease
001E01 Yasushi Ito [Japon] ; Masahiro Fujita [Japon] ; Shoichi Shimada ; Yoshiyuki Watanabe [Japon] ; Tomoya Okada [Japon] ; Hideo Kusuoka [Japon] ; Masaya Tohyama [Japon] ; Tsunehiko Nishimura [Japon]Comparison between the decrease of dopamine transporter and that of L‐DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models
001E03 Fukiko Ichida [Japon] ; Yuji Hamamichi [Japon] ; Toshio Miyawaki [Japon] ; Yasuo Ono [Japon] ; Tetsuro Kamiya [Japon] ; Teiji Akagi [Japon] ; Hiromichi Hamada [Japon] ; Osamu Hirose [Japon] ; Takeshi Isobe [Japon] ; Katsuhiko Yamada [Japon] ; Shunji Kurotobi [Japon] ; Hiroshi Mito [Japon] ; Toshiharu Miyake [Japon] ; Yasuo Murakami [Japon] ; Takeshi Nishi [Japon] ; Makoto Shinohara [Japon] ; Masashi Seguchi [Japon] ; Shinjiro Tashiro [Japon] ; Hirofumi Tomimatsu [Japon]Clinical features of isolated noncompaction of the ventricular myocardium
001E11 Yasuomi Ouchi [Japon] ; Etuji Yoshikawa [Japon] ; Hiroyuki Okada [Japon] ; Masami Futatsubashi [Japon] ; Yoshimoto Sekine [Japon] ; Masaomi Iyo [Japon] ; Masanobu Sakamoto [Japon]Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for β‐CFT binding with positron emission tomography
001E21 Akihiko Ogata [Japon] ; Kazuo Nagashima [Japon] ; Kotaro Yasui [Japon] ; Tohru Matsuura [Japon] ; Kunio Tashiro [Japon]Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats
001E26 Akira Kakizuka [Japon]Protein precipitation: a common etiology in neurodegenerative disorders?
001E34 R. Hayashi [Japon] ; N. Hanyu [Japon] ; F. Tamaru [Japon]Cognitive impairment in Parkinson's disease: a 6year follow-up study
001E39 Shinji Kinoshita [Japon] ; Takakazu Katoh [Japon]Apparent bradycardia-dependent block in the accessory pathway in intermittent Wolff-Parkinson-White syndrome
001E65 Yoshito Iesaka ; Teiichi Yamane ; Atsushi Takahashi ; Masahiko Goya ; Shigeyuki Kojima ; Yohkoh Soejima ; Yoshihiro Okamoto ; Hideomi Fujiwara ; Kazutaka Aonuma ; Akihiko Nogami ; Michiaki Hiroe ; Fumiaki Marumo ; Masayasu Hiraoka [Japon]Retrograde Multiple and Multifiber Accessory Pathway Conduction in the Wolff‐Parkinson‐White Syndrome:
001E77 Mizuno [Japon] ; Hiroyo Yoshino [Japon] ; Shin-Ichiro Ikebe [Japon] ; Nobutaka Hattori [Japon] ; Tomonori Kobayashi [Japon] ; Satoe Shimoda-Matsubayashi [Japon] ; Hiroto Matsumine [Japon] ; Tomoyoshi Kondo [Japon]Mitochondrial dysfunction in parkinson's disease
001E91 Nobutaka Hattori [Japon] ; Hiroyo Yoshino [Japon] ; Masashi Tanaka [Japon] ; Hiroshi Suzuki [Japon] ; Yoshikuni Mizuno [Japon]Genotype in the 24-kDa Subunit Gene (NDUFV2) of Mitochondrial Complex I and Susceptibility to Parkinson Disease
001F09 Teruhisa Yoshida [Japon] ; Hisao Ikeda [Japon] ; Tatsuro Hiraki [Japon] ; Ichiro Kubara [Japon] ; Masanobu Ohga [Japon] ; Tsutomu Imaizumi [Japon]Detection of concealed left sided accessory atrioventricular pathway by P wave signal averaged electrocardiogram
002059 Yoshito Iesaka ; Atsushi Takahashi ; Masahiko Goya ; Yohkoh Soejima ; Yoshihiro Okamoto ; Hideomi Fujiwara ; Kazutaka Aonuma [Japon] ; Akihtko Nogami [Japon] ; Michiaki Hiroe [Japon] ; Fumiaki Marumo [Japon] ; Masayasu Hiraoka [Japon]Adenosine‐Sensitive Atrial Reentrant Tachycardia Originating from the Atrioventricular Nodal Transitional Area
002135 Yoshimi Otani [Japon] ; Yasuo Morishita [Japon] ; Susumu Ishikawa [Japon] ; Yoshirou Hamada [Japon] ; Akio Otaki [Japon] ; Ichirou Yoshida [Japon] ; Takurou Misaki [Japon]Successful treatment of Wolff-Parkinson-White syndrome with concomitant mitral stenosis by simultaneous surgery
002142 Fumi Inaba-Sato [Japon] ; Makoto Hirai [Japon] ; Hiroshi Hayashi [Japon] ; Yukihiko Yoshida [Japon] ; Tetsuo Yanagawa [Japon] ; Yasushi Tomita [Japon] ; Kazuki Iwata [Japon] ; Kazunari Abe [Japon] ; Masayuki Terazawa [Japon] ; Makoto Akahoshi [Japon] ; Mikio Sugino [Japon] ; Hidehiko Saito [Japon]Relationship between QRS duration and repolarization abnormalities in patients with wolff-parkinson-white syndrome
002146 A. Yagishita [Japon] ; M. Oda [Japon]Progressive supranuclear palsy: MRI and pathological findings
002181 Akira Fujiki [Japon] ; Masanao Tani [Japon] ; Shigeki Yoshida [Japon] ; Hiroshi Inoue [Japon]Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia
002199 Takashi Kanda [Japon] ; Hiroshi Tsukagoshi [Japon] ; Masaya Oda [Japon] ; Kazuhito Miyamoto [Japon] ; Hitoshi Tanabe [Japon]Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson’s disease and multiple system atrophy
002208 Atsushi Harada [Japon] ; Kenji Sasaki [Japon] ; Takao Fukushima [Japon] ; Masatoshi Ikeshita [Japon] ; Tetsuo Asano [Japon] ; Shigeo Yamauchi [Japon] ; Shigeo Tanaka [Japon] ; Tasuku Shoji [Japon]Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve disease
002221 Yukio Akaneya [Japon] ; Mitsuo Takahashi [Japon] ; Hiroshi Hatanaka [Japon]Survival of and 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity against dopaminergic neurons in coculture of rat mesencephalon with their target or non-target regions
002222 H. Ohtake [Japon] ; T. Misaki [Japon] ; Y. Matsunaga [Japon] ; M. Tubota [Japon] ; M. Kawasuji [Japon] ; Y. Watanabe [Japon]Surgical therapy for Wolff-Parkinson-White syndrome in patients with bronchial asthma
002268 Shigeo Horinaka [Japon] ; Hideo Yamamoto [Japon] ; Teizou Tabuchi [Japon] ; Masanori Takada [Japon] ; Tomoyuki Akabane [Japon] ; Masafumi Onoda [Japon] ; Shigeru Yagi [Japon]Ventricular gradient variability
002272 Yoshihiko Watanabe [Japon]The state of body surface mapping in Japan
002279 Takuro Misaki [Japon] ; Go Watanabe [Japon] ; Takashi Iwa [Japon] ; Yoh Watanabe [Japon] ; Keiichi Mukai [Japon] ; Masao Takahashi [Japon] ; Hiroshi Ohtake [Japon] ; Keiichi Yamamoto [Japon]Surgical treatment of patients with Wolff-Parkinson-White syndrome and associated Ebstein's anomaly
002280 H. Ueda [Japon] ; K. Sato [Japon] ; F. Okumura [Japon] ; A. Inoue [Japon] ; Y. Nakata [Japon] ; N. Ozaki [Japon] ; J. L. Yue [Japon] ; Y. Misu [Japon]Supersensitization of neurochemical responses by L-DOPA and dopamine receptor agonists in the striatum of experimental Parkinson's disease model rats
002282 Claudia Schwab [Canada] ; C. Steele ; Haruhiko Akiyama [Japon] ; G. Mcgeer [Canada] ; L. Mcgeer [Canada]Relationship of amyloid β/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia
002290 Tetsuo Yanagawa [Japon] ; Makoto Hirai [Japon] ; Hiroshi Hayashi [Japon] ; Hiroaki Sano [Japon] ; Yasushi Tomita [Japon] ; Yasuya Inden [Japon] ; Hidehiko Saito [Japon]QRST time integral values in 12-lead electrocardiograms before and after radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome
002342 K. Nishiyama [Japon] ; S. Murayama [Japon] ; J. Shimizu [Japon] ; Y. Ohya [Japon] ; S. Kwak [Japon] ; K. Asayama [Japon] ; I. Kanazawa [Japon]Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study
002343 S. Takauchi [Japon] ; S. Yamauchi [Japon] ; Y. Morimura [Japon] ; K. Ohara [Japon] ; Y. Morita [Japon] ; S. Hayashi [Japon] ; K. Miyoshi [Japon]Coexistence of Pick bodies and atypical Lewy bodies in the locus ceruleus neurons of Pick's disease
002373 Junko Ito [Japon]Somatosensory event-related potentials (ERPs) in patients with different types of dementia
002381 Toshihiro Masaki [Japon] ; Shoichi Ishiura [Japon] ; Hideo Sugita [Japon] ; Shin Kwak [Japon]Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy
002394 Junko Fukushima [Japon] ; Kikuro Fukushima [Japon] ; Kazuo Miyasaka [Japon] ; Itaru Yamashita [Japon]Voluntary control of saccadic eye movement in patients with frontal cortical lesions and Parkinsonian patients in comparison with that in Schizophrenics
002399 H. Tachibana [Japon] ; K. Kawabata [Japon] ; Y. Tomino [Japon] ; M. Sugita [Japon] ; M. Fukuchi [Japon]Three-dimensional surface display of brain perfusion with123I-IMP in Parkinson's disease
002425 S. Umeki [Japon]Mechanisms for the activation/electron transfer of neutrophil NADPH-oxidase complex and molecular pathology of chronic granulomatous disease
002434 Osmar Antonio Centurion [Japon] ; Akihiko Shimizu [Japon] ; Shojiro Isomoto [Japon] ; Osamu Hano [Japon] ; Tetsuya Hirata [Japon] ; Atsushi Konoe [Japon] ; Muneshige Kaibara [Japon] ; Katsusuke Yano [Japon]Incidence and electrophysiologic characteristics of supernormal atrial conduction in humans
002525 J. Kawai [Japon] ; M. Sasahara [Japon] ; F. Hazama [Japon] ; S. Kuno [Japon] ; O. Komure [Japon] ; S. Nomura [Japon] ; M. Yamaguchi [Japon]Pallidonigroluysian degeneration with iron deposition: a study of three autopsy cases
002533 H. Tohgi [Japon] ; T. Abe [Japon] ; S. Takahashi [Japon] ; J. Takahashi [Japon] ; Y. Nozaki [Japon] ; M. Ueno [Japon] ; T. Kikuchi [Japon]Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes
002542 Takahiro Fukuda [Japon] ; Junichi Tanaka [Japon] ; Kazuhiko Watabe [Japon] ; Robert Tomohiko Numoto [Japon] ; Motoyuki Minamitani [Japon]Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain‐stem in Lewy body disease
002572 Yoshio Ichihara [Japon] ; Hiroshi Hayashi [Japon] ; Yasushi Tomita [Japon] ; Masayoshi Adachi [Japon] ; Kazumasa Kondo [Japon] ; Akira Suzuki [Japon] ; Makoto Nagasaka [Japon] ; Makoto Hirai [Japon] ; Hidehiko Saito [Japon]Small differences among body surface and epicardial QRST integral maps recorded during normal activation and experimentally simulated left bundle branch block or preexcitation in canine hearts
002586 Osmar Antonio Centurion [Japon] ; Masahiko Fukatani [Japon] ; Atsushi Konoe [Japon] ; Muneo Tanigawa [Japon] ; Akihiko Shimizu [Japon] ; Shojiro Isomoto [Japon] ; Mitsuo Kadena [Japon] ; Kunitake Hashiba [Japon]Electrophysiological abnormalities of the atrial muscle in patients with sinus node dysfunction without tachyarrhythmias
002588 W. Shimizu [Japon] ; T. Ohe [Japon] ; T. Kurita [Japon] ; H. Takaki [Japon] ; N. Aihara [Japon] ; S. Kamakura [Japon] ; M. Matsuhisa [Japon] ; K. Shimomura [Japon]Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White Syndrome
002590 Kazuhiko Miyaguchi [Japon] ; Jitsuki Tsuzuki [Japon] ; Mitsuhiro Yokota [Japon] ; Hiroshi Hayashi [Japon]Characteristic findings on the standard 12-lead ECG in patients with the fasciculoventricular Mahaim fiber
002601 Hisao Tachibana [Japon] ; Kazuo Toda [Japon] ; Minoru Sugita [Japon]Actively and passively evoked P3 latency of event-related potentials in Parkinson's disease
002614 T. Uchihara [Japon] ; H. Kondo [Japon] ; K. Kosaka [Japon] ; H. Tsukagoshi [Japon]Selective loss of nigral neurons in Alzheimer's disease: a morphometric study
002635 K. Kuroda [Japon] ; K. Tatara [Japon] ; T. Takatorige [Japon] ; F. Shinsho [Japon]Effect of physical exercise on mortality in patients with Parkinson's disease
002647 T. Itakura [Japon] ; M. Umemoto [Japon] ; I. Kamei [Japon] ; H. Imai [Japon] ; H. Yokote [Japon] ; Sh. Yukawa [Japon] ; N. Komai [Japon]Autotransplantation of peripheral cholinergic neurons into the brains of Alzheimer model rats
002754 T. Uchihara [Japon] ; K. Tsuchiya [Japon] ; K. Kosaka [Japon]Selective loss of nigral neurons in Pick's disease: a morphometric study
002778 K. Kosaka [Japon]Diffuse lewy body disease in Japan
002827 K. Mizukami [Japon] ; K. Kosaka [Japon]Neuropathological study on the nucleus basalis of Meynert in Pick's disease
002890 Yukishige Yanagawa [Japon] ; Hitoshi Sakuraba [Japon]Cardiovascular Manifestations in Fabry's Disease — Age‐Related Changes in Hemizygotes and Heterozygotes —
002957 G. Barrett [Japon] ; H. Shibasaki [Japon] ; R. Neshige [Japon]Cortical potential shifts preceding voluntary movement are normal in parkinsonism
002A91 M. Yoshimura [Autriche, Japon]Cortical changes in the parkinsonian brain: a contribution to the delineation of “diffuse Lewy body disease”
002B43 Takashi Iwa [Japon] ; Michio Kawasuji [Japon] ; Takuro Misaki [Japon] ; Tatsuo Magara [Japon] ; Keiichi Mukai [Japon] ; Hiroaki Kobayashi [Japon]Surgical treatment of the Wolff-Parkinson-White syndrome in infants and children
002C11 Hiroshi Shibasaki [Japon] ; Fumio Shima [Japon] ; Yoshigoro Kuroiwa [Japon]Clinical studies of the movement-related cortical potential (MP) and the relationship between the dentatorubrothalamic pathway and readiness potential (RP)
002D13 Takashi Ban [Japon] ; Masakazu Hojo [Japon]A comparative study of the effects of anti-parkinson drugs on the oxotremorine-induced EEG and muscular activities

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024